Ranking · Winter 2017 · Healthcare · Diagnostics

Delee

Blood testing device for early diagnosis of cancer and treatment…

3.3%

odds of being acquired in the next two years

0.5× the average (6.8%)

#4289 of 4,339 active YC companies · top 100%

Team of 18 · Monterrey, N.L., Mexico

Raises the odds

↑ changed its name (pivot)

Lowers the odds

↓ based in Latin America

↓ industry: Healthcare

↓ sector: Diagnostics

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Delee's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

delee.co YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub